Splanchnic vein thrombosis associated with myeloproliferative neoplasms

被引:15
作者
Tremblay, Douglas [1 ,5 ]
Winters, Adam [2 ]
Beckman, Joan D. [3 ]
Naymagon, Leonard [1 ]
Patel, Rahul [4 ]
Mascarenhas, John [1 ]
Schiano, Thomas D. [2 ]
机构
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Recanati Miller Transplantat Inst, Div Liver Dis, New York, NY USA
[3] Univ Minnesota, Div Hematol Oncol & Transplantat, Med Sch, Minneapolis, MN USA
[4] Icahn Sch Med Mt Sinai, Div Intervent Radiol, New York, NY USA
[5] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Myeloproliferat Disorders Program, Div Hematol Oncol, One Gustave L Levy Pl,Box 1079, New York, NY 10029 USA
关键词
Splanchnic vein; Thrombosis; Myeloproliferative; Polycythemia vera; Essential thrombocythemia; Myelofibrosis; BUDD-CHIARI-SYNDROME; VENOUS THROMBOSIS; ENDOTHELIAL-CELLS; JAK2; MUTATION; MYELOFIBROSIS; DIAGNOSIS; JAK2V617F; RISK; PREVALENCE; IMPACT;
D O I
10.1016/j.thromres.2022.08.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Splanchnic vein thrombosis (SVT) in the setting of myeloproliferative neoplasm (MPN) is a unique clinical entity that requires close interdisciplinary coordination for proper diagnosis and management. The pathobiology of MPN-SVT is not fully understood, but recent developments have revealed the central role of endothelial cells. In this multidisciplinary review, we summarize the epidemiology of MPN-SVT and then critically evaluate the pathogenic features of this complication, with a focus on endothelial cell biology. We then discuss diagnostic considerations, including imaging modalities and MPN-specific investigations. Finally, we critically review the evidence supporting clinical management of MPN-SVT, including anticoagulation, interventional radiology procedures, MPN-related therapies, and liver transplantation. We conclude that further studies are needed to improve our understanding of MPN-SVT and the outcomes of patients with this debilitating complication.
引用
收藏
页码:8 / 16
页数:9
相关论文
共 78 条
[51]  
Ögren M, 2006, WORLD J GASTROENTERO, V12, P2115
[52]   Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial [J].
Ordi-Ros, Josep ;
Saez-Comet, Luis ;
Perez-Conesa, Mercedes ;
Vidal, Xavier ;
Riera-Mestre, Antoni ;
Castro-Salomo, Antoni ;
Cuquet-Pedragosa, Jordi ;
Ortiz-Santamaria, Vera ;
Mauri-Plana, Montserrat ;
Sole, Cristina ;
Cortes-Hernandez, Josefina .
ANNALS OF INTERNAL MEDICINE, 2019, 171 (10) :685-+
[53]   Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo [J].
Pan, Junliang ;
Dinh, Thanh Theresa ;
Rajaraman, Anusha ;
Lee, Mike ;
Scholz, Alexander ;
Czupalla, Cathrin J. ;
Kiefel, Helena ;
Zhu, Li ;
Xia, Lijun ;
Morser, John ;
Jiang, Haiyan ;
Santambrogio, Laura ;
Butcher, Eugene C. .
BLOOD, 2016, 128 (01) :104-109
[54]  
PEARSON TC, 1978, LANCET, V2, P1219
[55]   Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms [J].
Pieri, Lisa ;
Paoli, Chiara ;
Arena, Umberto ;
Marra, Fabio ;
Mori, Fabio ;
Zucchini, Mery ;
Colagrande, Stefano ;
Castellani, Alessandro ;
Masciulli, Arianna ;
Rosti, Vittorio ;
De Stefano, Valerio ;
Betti, Silvia ;
Finazzi, Guido ;
Ferrari, Maria Luisa ;
Rumi, Elisa ;
Ruggeri, Marco ;
Nichele, Ilaria ;
Guglielmelli, Paola ;
Fjerza, Rajmonda ;
Mannarelli, Carmela ;
Fanelli, Tiziana ;
Merli, Lucia ;
Fattori, Giuditta Corbizi ;
Massa, Margherita ;
Cimino, Giuseppe ;
Rambaldi, Alessandro ;
Barosi, Giovanni ;
Cazzola, Mario ;
Barbui, Tiziano ;
Vannucchi, Alessandro M. .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (02) :187-195
[56]   Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm [J].
Poisson, Johanne ;
Tanguy, Marion ;
Davy, Hortense ;
Camara, Fatoumata ;
El Mdawar, Marie-Belle ;
Kheloufi, Marouane ;
Dagher, Tracy ;
Devue, Cecile ;
Lasselin, Juliette ;
Plessier, Aurelie ;
Merchant, Salma ;
Blanc-Brude, Olivier ;
Souyri, Michele ;
Mougenot, Nathalie ;
Dingli, Florent ;
Loew, Damarys ;
Hatem, Stephane N. ;
James, Chloe ;
Villeval, Jean-Luc ;
Boulanger, Chantal M. ;
Rautou, Pierre-Emmanuel .
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05) :2630-2643
[57]   Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study [J].
Poisson, Johanne ;
Plessier, Aurelie ;
Kiladjian, Jean-Jacques ;
Turon, Fanny ;
Cassinat, Bruno ;
Andreoli, Annalisa ;
De Raucourt, Emmanuelle ;
Goria, Odile ;
Zekrini, Kamal ;
Bureau, Christophe ;
Lorre, Florence ;
Cervantes, Francisco ;
Colomer, Dolors ;
Durand, Francois ;
Garcia-Pagan, Juan-Carlos ;
Casadevall, Nicole ;
Valla, Dominique-Charles ;
Rautou, Pierre-Emmanuel ;
Marzac, Christophe .
JOURNAL OF HEPATOLOGY, 2017, 67 (03) :501-507
[58]   Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis [J].
Praktiknjo, Michael ;
Trebicka, Jonel ;
Carnevale, Roberto ;
Pastori, Daniele ;
Queck, Alexander ;
Ettorre, Evaristo ;
Violi, Francesco .
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11
[59]   Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis [J].
Primignani, Massimo ;
Barosi, Giovanni ;
Bergamaschi, Gaetano ;
Gianelli, Umberto ;
Fabris, Federica ;
Reati, Raffaella ;
Dell'Era, Alessandra ;
Bucciarelli, Paolo ;
Mannucci, Pier Mannuccio .
HEPATOLOGY, 2006, 44 (06) :1528-1534
[60]   Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis [J].
Rampal, Raajit ;
Al-Shahrour, Fatima ;
Abdel-Wahab, Omar ;
Patel, Jay P. ;
Brunel, Jean-Philippe ;
Mermel, Craig H. ;
Bass, Adam J. ;
Pretz, Jennifer ;
Ahn, Jihae ;
Hricik, Todd ;
Kilpivaara, Outi ;
Wadleigh, Martha ;
Busque, Lambert ;
Gilliland, D. Gary ;
Golub, Todd R. ;
Ebert, Benjamin L. ;
Levine, Ross L. .
BLOOD, 2014, 123 (22) :E123-E133